Japan Approves Pfizer's Xalacom For Glaucoma
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare Jan. 20 approved Pfizer's Xalacam (latanoprost/ timolol) eye drops for glaucoma and ocular hypertension. Latanoprost and timolol work together to decrease eye pressure in a once-daily formulation that decreases pressure for 24 hours. Xalacom is the first combo glaucoma drug approved in Japan. (Click here for more - Japanese language)